Aclarion, Inc. (ACON)
Nasdaq · Services-Medical Laboratories · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-11 | Bond Ryan | officer | A | 55,000 | 0 | $0 |
| 2026-06-11 | Sequira Amanda Mae | director | A | 20,000 | 0 | $0 |
| 2026-06-11 | Gould Gregory A | officer | A | 50,000 | 0 | $0 |
| 2026-06-11 | Breidbart Scott | director | A | 20,000 | 0 | $0 |
| 2026-06-11 | Ness Brent | director | A | 100,000 | 0 | $0 |
| 2026-06-11 | Wesemann William | director | A | 20,000 | 0 | $0 |
| 2026-06-11 | Neal David K | director | A | 20,000 | 0 | $0 |
| 2026-06-11 | Thramann Jeffrey John | director | A | 100,000 | 0 | $0 |
| 2026-06-11 | Deitsch Stephen | director | A | 20,000 | 0 | $0 |
| 2026-05-12 | Breidbart Scott | director | P | 5,664 | 3.18 | $18,012 |
| 2026-05-11 | Neal David K | director | P | 2,500 | 3.1 | $7,750 |
| 2026-05-11 | Ness Brent | director | P | 6,289 | 3.18 | $19,999 |
| 2026-05-06 | Wesemann William | director | P | 1,562 | 3.3 | $5,155 |
| 2025-11-26 | Ness Brent | director | P | 10 | 6.2 | $62 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.